VivoSeq
Other

Critical Care

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Critical Care is an early-stage landscape with 0 programs across 1 company. The most active players are Institut d'Investigacions Biomèdiques August Pi i Sunyer.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed9 · 60%
Unknown status2 · 13%
Terminated1 · 7%
Not yet recruiting1 · 7%
Recruiting1 · 7%
Withdrawn1 · 7%

Trial Activity

15 trials

Early Optimization of Ceftazidime Regimen in Critical Care
Not yet recruiting··N/A·NCT07085624·128 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)